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Abstract
Background: Despite abundant bereavement care options, consensus is lacking regarding optimal
care for bereaved persons.
Methods: We conducted a systematic review, searching MEDLINE, PsychINFO, CINAHL, EBMR,
and other databases using the terms (bereaved or bereavement) and (grief) combined with
(intervention or support or counselling or therapy) and (controlled or trial or design). We also
searched citations in published reports for additional pertinent studies. Eligible studies had to
evaluate whether the treatment of bereaved individuals reduced bereavement-related symptoms.
Data from the studies was abstracted independently by two reviewers.
Results: 74 eligible studies evaluated diverse treatments designed to ameliorate a variety of
outcomes associated with bereavement. Among studies utilizing a structured therapeutic
relationship, eight featured pharmacotherapy (4 included an untreated control group), 39 featured
support groups or counselling (23 included a control group), and 25 studies featured cognitive-
behavioural, psychodynamic, psychoanalytical, or interpersonal therapies (17 included a control
group). Seven studies employed systems-oriented interventions (all had control groups). Other
than efficacy for pharmacological treatment of bereavement-related depression, we could identify
no consistent pattern of treatment benefit among the other forms of interventions.
Conclusions: Due to a paucity of reports on controlled clinical trails, no rigorous evidence-based
recommendation regarding the treatment of bereaved persons is currently possible except for the
pharmacologic treatment of depression. We postulate the following five factors as impeding
scientific progress regarding bereavement care interventions: 1) excessive theoretical
heterogeneity, 2) stultifying between-study variation, 3) inadequate reporting of intervention
procedures, 4) few published replication studies, and 5) methodological flaws of study design.
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Background
Give sorrow words; the grief that does not speak
Whispers the o'er fraught heart and bids it break.
Shakespeare, Macbeth IV, iii, 209
Grieving the death of a loved one has an ancient history:
from time immemorial, cultures have provided the
bereaved with advice and rituals to address – and express
– the experience of grief [1]. Over the past several decades,
efforts to aid the bereaved have increasingly focused on
the physical and psychological morbidity, and the spirit-
ual suffering and social isolation associated with bereave-
ment. The resulting plethora of intervention options,
ranging from mutual-help support groups to prescribed
pharmacotherapy and professionally led psychotherapy,
is striking, as is the panoply of settings in which bereave-
ment care can be found: hospitals, hospices, churches,
palliative care units, community-based services, and
bereavement-specific foundations all provide an array of
bereavement care interventions. This welter of activity tes-
tifies to the broadly valued goal of decreasing the severity
of bereavement-related symptoms.
Given the abundance of care options, what is the best way
to care for a bereaved person? Numerous studies measur-
ing the impact of bereavement interventions have been
published in diverse journals, yet no consensus has
emerged in the medical, mental health, or social work
communities regarding whether one form of treatment is
preferable to another [2-5]. We therefore have conducted
a systematic review of bereavement care interventions.
Our goal is to present a comprehensive yet coherent syn-
thesis of the current literature that will promote the
advancement in the quality of care and research on behalf
of bereaved individuals.
Methods
Data sources
To identify studies in the traditional medical literature as
well as the complementary and alternative medicine liter-
ature, we searched the following databases: MEDLINE;
PsychINFO; Cumulative Index to Nursing and Allied
Health (CINAHL); BIOSIS Previews; ISI Science Citation
Index Expanded and Social Sciences Index; Evidence
Based Medicine Reviews (EBMR), including the Cochrane
Database of Systematic Reviews (DSR), the Cochrane
Controlled Trial Registry (CCTR), Database of Abstracts of
Reviews of Effectiveness (DARE), and the American Col-
lege of Physicians' (ACP) Journal Club Review; Sociologi-
cal Abstracts; Alt HealthWatch; and Wilson Web from
1966 to 2003. We identified all relevant articles on
bereavement care interventions by using the primary
search terms of "bereaved or bereavement" and "grief", com-
bined with secondary descriptors of "intervention or sup-
port or counselling or therapy" and "controlled or trial or
design".
Study selection
Our inclusion criteria specified that each study: 1)
addressed the treatment of bereaved individuals, and 2)
included an evaluation of a selected method of therapy
aimed at reducing the grief reaction due to bereavement.
We considered only articles written in the English lan-
guage. We then reviewed the titles and abstracts of all arti-
cles we retrieved through our initial database search, and
obtained the full texts of all applicable studies. We also
reviewed the references in all applicable studies for addi-
tional pertinent studies.
Data extraction
The full articles of all studies that met inclusion criteria
and passed subsequent title and abstract reviews were
retrieved and examined independently by two of the
authors. Each article was reviewed for measured out-
comes, patient and decedent characteristics, and interven-
tion characteristics. These measures included sample size,
type of intervention, length of intervention, patient's rela-
tionship to the deceased, time since the bereaved death,
and patient demographics. Data was extracted and any
disagreements were resolved through discussion, clarifica-
tion, and consensus within the research team.
Characteristics of reviewed studies
The initial literature search generated 737 citations. Elim-
ination of duplicate citations yielded 340 references. 2
studies, written in Chinese and Spanish, were excluded.
Reviewing the titles culled the sample to 243 citations,
and a review of the abstracts found 87 of these to be
potentially relevant. Of these, 9 were dissertations, 2 were
irretrievable, 2 were duplicate publications of the same
study, and 15 were ineligible because they did not meet
our inclusion criteria. The resulting set of 74 articles was
subject to review for data extraction. A list of all citations
found, including those excluded from this analysis, is
available [see Additional file 1].
Of the 74 studies that met inclusion criteria, almost 6,000
participants within these studies experienced a multitude
of losses – of parents, spouses, children, and other loved
ones who had died from a wide range of causes, both sud-
den and protracted. The therapies utilized and outcomes
evaluated varied widely. Heterogeneity among both the
outcomes and the measures used to assess similar out-
comes precluded an effort to summarize data across stud-
ies, even in the form of generic effect-size measures.
Furthermore, for a significant portion of the studies, con-
cerns regarding the internal or external validity of theBMC Palliative Care 2004, 3:3 http://www.biomedcentral.com/1472-684X/3/3
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reported results cautioned against making quantitative
summary statements regarding treatment effects.
Results
The 74 studies selected for detailed review evaluated
diverse types of interventions designed to ameliorate the
adverse physical and psychological outcomes associated
with bereavement. These interventions can be classified
according to various schemes, including their underlying
theoretical framework (ranging from Freudian psychoa-
nalysis to neurotransmitter imbalances), the format of the
intervention (individual, group, family, marital), the tim-
ing of the intervention (acute, intermittent crisis,
chronic), the tasks assigned to the bereaved (ranging from
verbalizing feelings to taking medication), or the popula-
tion targeted for the intervention (children, adults, sen-
iors). We chose to organize this review on the basis of the
social framework used to implement the intervention
(that is, either personalized structured therapeutic rela-
tionships or less personal systems-level interventions), as
this attribute of the interventions emerged as the most ver-
ifiable and salient measure.
Structured therapeutic relationship
Eight studies feature pharmacotherapy, but only four com-
pared active therapy to non-pharmacotherapy controls,
and only one study clearly reported their random alloca-
tion method (Table 1) [6-13]. These studies targeted
adults and seniors, ranged in sample size from 10–80 sub-
jects, and used a variety of drugs, including tricyclic anti-
depressants (TCA), selective serotonin reuptake inhibitors
(SSRI), buprioion, and benzodiazepines. Overall, these
studies demonstrated a statistically significant beneficial
effect of pharmacotherapy on ameliorating symptoms of
depression and improving subjective sleep quality [6-
11,13]. These benefits persisted only as long as the sub-
jects continued to receive pharmacotherapy. Pharmaco-
therapy was found, however, to have a mixed effect on
bereavement intensity as measured by symptoms of grief
(i.e., Texas Revised Inventory of Grief, Inventory of Com-
plicated Grief). For example, Warner and colleagues
(2001) did not find evidence of an effect of benzodi-
azepines (diazepam) on bereavement-related grief inten-
sity[12]. One study combined pharmacotherapy with
psychotherapy in a 16-week double-blinded factorial
design trial of nortriptyline (NT) and interpersonal psy-
chotherapy [6]. The 80 patients were randomly assigned
to one of four treatment conditions: NT plus interpersonal
psychotherapy, NT plus medication clinic (i.e., no inter-
personal psychotherapy), placebo pill plus interpersonal
psychotherapy, and placebo pill plus medication clinic
(i.e., no interpersonal psychotherapy conditions). Details
of the psychotherapy were not described. While the results
displayed a statistically significant benefit of nortriptyline
over placebo regarding remission of depression, none of
the treatment conditions were associated with diminish-
ment of grief.
Support groups or counselling constituted the intervention
in 39 studies, of which 23 had control groups and 15
claimed random allocation, yet only three of these
included clearly described allocation methods (Table 2)
[14-52]. Ten of these were mutual/self-help, with the
majority taking the form of informal group therapy. The
remaining 29 studies were professionally led support
groups targeting select subgroups including parentally
bereaved children, college students, and seniors, as well as
many specific adult populations. Program implementa-
tion across studies varied even further. This variation was
found in terms of number of sessions (one to 25),
whether the sessions proceeded with full-fledged patient-
driven discussion or highly structured protocols, whether
attendance was mandatory or individually motivated, as
well as in the nature of the group leadership and the for-
mat (individual, group, or marital). Perhaps due to these
or other differences in the interventions, some studies
documented study treatment effects [22,26,29-
31,33,34,52] while other studies showed no effect
[15,17,27,37,46,51].
Several studies documented substantial spontaneous
improvements in bereavement symptomology in the con-
trol groups. Kay and others (1993) report a bereavement
intervention for Mexican-American widows [33]. They
found that all widows improved on all depression scales,
state anxiety, life satisfaction, and emotional and somatic
symptom scales over the course of two years. However,
those widows in the experimental support group exhibit
significantly improved changes in these scores. Tudiver
and colleagues (1992) conducted a mutual-help support
group for recently bereaved widowers [17] that can be
compared to Vachon and colleagues' (1980) and Barrett's
(1978) widow studies [14,39]. Tudiver and others found
significant improvement over time (baseline to eight
months) for all widowers, but found no significant differ-
ences between those who received treatment and a com-
parison group of windowers who were on the wait list to
receive treatment but had not.
Psychotherapy-based treatments, another form of psycho-
logical interventions, can be done in different formats
(family, group, or individual), and via different
approaches. Of the 25 studies that use psychotherapy as
an intervention, approaches included cognitive-behavio-
ral, psychodynamic, psychoanalytical, and interpersonal
approaches, as well as combinations of these and modal-
ity and social support (Table 3)[6,19,22,35,38,53-72].
Seventeen of these studies utilized control groups, only 13
claimed randomization, and only five of these clearly
stated their method of allocation.BMC Palliative Care 2004, 3:3 http://www.biomedcentral.com/1472-684X/3/3
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Cognitive-behavioral therapy was employed in nine trials,
four of which used individual sessions while five studies
used group sessions. Murphy and colleagues (1998) stud-
ied an intervention for parents bereaved by the violent
death of their children [57]. The results show no treatment
effect between intervention and control groups over the five
main tested outcome variables. The authors then pro-
ceeded with a post-hoc subgroup analysis, which identified
mothers with high Global Severity Index scores and grief at
baseline as potentially benefiting from intervention during
the period, while fathers who received the intervention
appeared to have more posttraumatic stress disorder
(PTSD) symptoms at six-month follow-up.
Kleber and Brom (1987) conducted a comparative out-
come study of three forms of short-term psychotherapy
[69]. They compared the results of 83 patients suffering
from a major loss who had been randomized into
hypnotherapy (behavioral), trauma desensitization
(behavioral), psychodynamic therapy, and a delayed-treat-
ment control group. They found all three therapies success-
ful in improving patients' conditions, but did not find any
particular therapy to be significantly more effective than
another. While the control group showed slight recovery,
over time the three therapies were more effective in reduc-
ing symptoms of the bereavement response.
Studies of psychodynamic  therapy, which strives for the
patient to understand and cope better with feelings by re-
experiencing them and talking them through with the aid
of the therapist, was found to be quite prevalent in the
bereavement care literature. Overall, the results are mixed,
with more support found in the group format of psychody-
namic therapy than in individual therapy. Of the studies we
evaluated as psychodynamic therapy, six were individual in
format, seven had a group format, and eight employed con-
trol groups; five of these claimed random allocation (one
additional study randomly assigned subjects to two experi-
mental conditions but lacked a control group).
Psychoanalysis, as exemplified by Freud, proceeds with an
inward investigation of unconscious mental processes
and childhood experiences as the principal therapeutic
procedure. Problematic measurement methodology beset
the one study that utilized a group format to provide a
psychoanalytic-based intervention (with no details
regarding the tasks assigned to the patients)[68]. This
study focused primarily on the relationship between the
Table 1: Pharmacotherapy Interventions
Medication Pop CG RA Num* TSL (days) Dose DT (days) Key Outcome 
Measures
Article
Nortriptyline Senior Y Y-NE 80/66 216–279 Steady-state plasma level: 
50–120 ng/mL
112 Depression (HAM-D); 
Grief (TRIG)
Reynolds, 
Miller, et al, 
1999**
Senior Y Y-NE 27/27 210 (mean) Steady-state plasma level: 
79.9+/-28.3 ng/mL
Daily dose: 70.8+/-22.2 mg
<180 Sleep (PSQI); 
Depression (HAM-D, 
BDI)
Taylor, 
Reynolds, et 
al, 1999
Senior Y NR 30/24 276 Steady-state plasma level: 
72.7 ng/mL
Daily dose: 53.0 mg
112 Sleep (PSQI) Pasternak, 
Reynolds, et 
al, 1994
Senior N NA 13/13 150–750 Daily dose: 49.2 mg 9–184 Depression (HAM-D, 
BDI, BSI); Grief (TRIG, 
JGI); Sleep (PSQI)
Pasternak, 
Reynolds, et 
al, 1991
Nortriptyline 
and 
Paroxetine
Adult N NA 21/15 183–4158 PT Daily dose: 20–50 mg
NT Daily dose: 50–160 mg
120 Depression (HAM-D); 
Grief (ICG); Sleep 
(PSQI)
Zygmont, 
Prigerson, 
et al, 1998
Desipramine Adult N NA 10/9 NR Daily dose: 75–150 mg 28 Depression (HDRS, 
CGI, Raskin DS); Grief 
(Separation Distress)
Jacobs, 
Nelson, et 
al, 1987
Bupropion Adult N NA 22/14 42–56 Daily dose: 150–300 mg 56 Grief (TRIG, ICG); 
Depression (HAM-D)
Zisook, 
Schuchter, 
et al, 2001
Diazepam Senior Y Y 35/30 <14 2 mg/pill, self-administered <42 Bereavement (BPQ) Warner, 
Metcalfe, et 
al, 2001
Notes: * All Ns are reported as (starting population of bereaved individuals/bereaved population completing all follow-ups), unless only study 
included only one assessment. ** Study also included psychotherapy condition. Legend: Pop, Target Population; CG, Control Group; RA, Random 
Assignment; Num, Number of subjects; TSL, Time Since Loss; DT, Duration of Trial; NA, Not Applicable; NR, Not Reported; UC, Unclear; Y, Yes; 
N, No; Y-NE, Randomization mentioned, but allocation method not explicitly stated; RS, Randomization Subverted.BMC Palliative Care 2004, 3:3 http://www.biomedcentral.com/1472-684X/3/3
Page 5 of 14
(page number not for citation purposes)
Table 2: Support/Counselling Interventions
Type Format Pop CG RA Num TSL (days) DT Key Outcome Measures Article
Mutual/Self-help Individual Adult Y Y-NE 162/62 ~30 NR Psychiatric Functioning (GHQ); 
Social Support/psychological and 
psychophysiological variables 
(author-created)
Vachon, 
Lyall, et al, 
1980
Mutual/Self-help 
(included 
professionally-
lead groups)
Group Senior Y RS 339/295 30–60 56, 365 days Self-Esteem (Rosenberg's Self-
Esteem Scale); Life Satisfaction (LSI-
A); Depression (GDS); Grief 
(TRIG)
Caserta & 
Lund, 1983
Mutual/Self-help Group Senior Y N 23 34–474 21 days; 7 
sessions
Domain Specific State Locus of 
Control (Zeigler-Reid State Locus 
of Control Measure); Trait Locus 
of Control (I-E); Distress (BSI, GSI)
McKibbin, 
Guarnaccia, 
et al, 1997
Mutual/Self-Help Group Adult Y Y 113/67 90–365 63 days; 9 
sessions
Depression (GHQ, BDI); Anxiety 
(STAI); Social Functioning (SAS); 
Social Support (SSQ)
Tudiver, 
Hilditch, et 
al, 1992
Mutual/Self-help Group Adult Y Y-NE 113/112 90–365 63 days Healthcare visit rates (Family 
Physician, Specialist, Psychiatrist)
Tudiver, 
Permaul-
Woods, et 
al, 1995
Mutual/Self-help Group Adult Y N 38/21 90–750 70 days; 10 
sessions
Treatment Expectancy (Expectancy 
Scale); Depression (BDI); 
Avoidance, Anxiety (Social Anxiety 
and Distress Scale); Enjoyability 
(Pleasant Events Scale); Life 
Satisfaction (Life Satisfaction Scale)
Walls & 
Meyers, 
1985
Mutual/Self-help Group Adult Y N 721/502 ~1290 365 days; >3 
sessions
Depression, Anxiety, Somatization 
(Hopkins Symptom Checklist); Self 
Esteem, Well-being, Mastery (Not 
reported)
Lieberman 
& Videka-
Sherman, 
1986
Mutual/Self-help Group Adult Y N 667/391 365–1095 365 days Depression, Anxiety, Somatization 
(Not reported); Self Esteem 
(Rosenberg 1965); Life Satisfaction, 
Mastery, Medication (Not 
reported); Social Functioning 
Parental Functioning Attitudes 
(BPQ)
Videka-
Sherman & 
Lieberman, 
1985
Mutual/Self-help Group Adult N Y-NE 61/55 120–1095 84 days; 12 
sessions
Avoidance/Intrusion (IES); Stress 
Symptoms (SRRS); Depression 
(BDI); Mental Distress (BPRS, SCL-
90); Social Functioning (SAS-SR); 
Overall Functioning (GAS)
Marmar, 
Horowitz, 
et al, 1988**
Mutual/Self-help Group Adult N NA 53/33 <730 8 sessions, 
optional 4
Psychosomatic Symptoms (SCL-90 
subscales: somatization, obsessive-
compulsive, interpersonal 
sensitivity, depression, anxiety, 
hostility, phobic anxiety, paranoid 
ideation, psychoticism, GSI)
Rogers, 
Sheldon, et 
al, 1982
Professionally 
Lead
Individual Adult Y NR 493/225 120 1 day; 1 
session
Grief (HGRC) Kaunonen, 
Tarkka, et 
al, 2000
Professionally 
Lead
Family Adult Y Y-NE 50/30 1–2 1–120 days; 
up to 8 
sessions
General Health Questionnaire 
(self-rated); Anxiety, Depression 
(Leeds Scale)
Forrest, 
Standish, & 
Baum, 1982
Professionally 
Lead
Family Adult Y UC 334/
161*
<1–180 7–70 days; 
up to 10 
sessions
Medical Illness (CMI, MMPI); 
Psychiatric Illness (Boston 
Bereavement, Mood Inventory); 
Family Functioning (Ferriera-
Winter, Bodin Drawing); Crisis 
Coping (Intrapersonal, Family, Job/
Financial, Social); Social Cost 
(Gross Income, Living Expenses, 
Absenteeism, Economic Loss)
Williams, 
Lee, & 
Polak, 1976 
Polak, Egan, 
et al, 1975BMC Palliative Care 2004, 3:3 http://www.biomedcentral.com/1472-684X/3/3
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Professionally 
Lead
Family Adult Y UC 176/86* <1–180 7–70 days; 
up to 10 
sessions
Neurotic Symptoms Scale; Bodin 
Family Closeness; Crisis Coping 
Scale; Religious helping of others; 
Authoritarian Family Functioning; 
Depression; Monthly Income; 
Monthly Expenses; Social Costs; 
Bereavement Adjustment
Williams & 
Polak, 1979
Professionally 
Lead
Family Adult N NA 77/37* <1 >360 days Personal and social phenomena of 
death (structured interview)
Oliver, 
Sturtevant, 
et al, 2001
Professionally 
Lead
Family Child Y Y-NE 72/55 <730 15 sessions Depression (CDI, CBCL, PERI 
Demoralization Scale); Parental 
Warmth (CRPBI); Family Cohesion 
(Family Environment Scale); Parent 
perception of support (author-
created scale); Family Coping (F-
COPES)
Sandler, 
West, et al, 
1992
Professionally 
Lead
Group Senior N NR 28/11 90–7300 <140 days; 
up to 20 
sessions
Social Support (ASSIS); Affect/
Mood (PANAS); Emotional/Social 
Loneliness (ESLI)
Stewart, 
Craig, et al, 
2001
Professionally 
Lead
Group Adult Y Y 197/166 <180 70 days; 10 
sessions
Grief (TRIG, GRI); Distress 
(POMS); Depression and Anxiety 
(SIGH-AD)
Goodkin, 
Blaney, et al, 
1999
Professionally 
Lead
Group Adult Y Y-NE 242/185 0–35 77 days; 3 
sessions
Distress (POMS-TMD, Anxiety-
tension, Depression-dejection, 
Anger-hostility, Confusion-
bewilderment, Overall emotional 
disturbance); Self-Esteem 
(Rosenberg 1965 scale)
Swanson, 
1999
Professionally 
Lead
Group Adult Y Y-NE 150/120 30–240 270 days Depression (CES-D, BDI); Anxiety 
(A-Sta); Somatic Symptoms (SOM); 
Emotional Symptoms (EMOT); Life 
Satisfaction (Lsat, SelfAnch)
Kay, 
Guernsey 
de Zapien, 
et al, 1993
Professionally 
Lead
Group Adult Y Y-NE 119/119 <180 70 days; up 
to 10 
sessions
Immunological measures 
(CD3+CD4+ cell count, 
CD3+CD8+ cell count, CD4/CD8 
ratio, CD3+ cell count, CD4 cell 
count, Lymphocyte count, T-
lymphocyte count); 
Neuroendocrine measure (Plasma 
cortisol level)
Goodkin, 
Feaster, et 
al, 1998
Professionally 
Lead
Group Adult Y Y-NE 110/80 ~730 28 days; 8 
sessions
Coping and Adaptation (TAT) Balk, Lampe, 
et al, 1998
Professionally 
Lead
Group Adult Y Y-NE 36/36 <180 70 days; up 
to 10 
sessions
Plasma Viral Load (HIV-1 RNA 
copy number)
Goodkin, 
Baldewicz, 
et al, 2001
Professionally 
Lead
Group Adult Y N 159/127 42–140 Up to 25 
sessions
Social Support (SSES); Group 
Involvement (Liberman & Videka-
Sherman, 1986); Depression (CES-
D, POMS-D); Anger (POMS-A); 
Anxiety (POMS-T); Stress (IES)
Levy, 
Derby, et al, 
1993
Professionally 
Lead
Group Adult Y N 121 30–4745 30–365 days Grief (HGRC subscales: Despair, 
Panic behavior, Personal growth, 
Blame and Anger, Detachment, 
Disorganization)
DiMarco, 
Menke, & 
McNamara, 
2001
Professionally 
Lead
Group Adult N Y 139/107 90–17155 84 days; 12 
sessions
Avoidance/Intrusion (IES); Grief 
(TRIG); Interpersonal Distress 
(IIP); Social Functioning (SAS-SR); 
Depression (BDI); Anxiety (STAI); 
Mental Distress (BSI, GSI); Self-
Esteem (SES); Physical Functioning 
(SF-36); Symptomatic Distress 
(SCL-90)
Piper, 
McCallum, 
et al, 2001**
Table 2: Support/Counselling Interventions (Continued)BMC Palliative Care 2004, 3:3 http://www.biomedcentral.com/1472-684X/3/3
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patient's personal affect (measured by an unvalidated
affect assessment scale) and a favorable treatment out-
come (measured again by an ad-hoc unvalidated
measure).
Behavioral therapy uses learning principles (such as
behavior modification, systematic desensitization, and
aversion) to eliminate or reduce unwanted reactions to
either external situations, one's thoughts and feelings, and
Professionally 
Lead
Group Adult N N 83/70 <30–8030 49 days; 7 
sessions
Physical, Emotional, and Social 
Functioning (author created 
measures); Self Esteem (Rosenberg, 
1962); Locus of Control (I-E); Life 
satisfaction (Neugarten, 
Havighurdt, & Tobin, 1961); 
Attitude Toward Women (Spence 
& Helmreich, 1972, Gump 1972)
Barrett, 
1978
Professionally 
Lead
Group Adult N NA 392/77 NR 56 days Distress (BSI); Group Process and 
Satisfaction (author created 
questionnaire)
Glajchen & 
Magen, 1995
Professionally 
Lead
Group Adult N NA 174/138 780 730 days Motives for joining (Lieberman 
1979); Interpersonal relations 
(Porat 1987); Group leadership 
style (Porat 1987); Perceived 
contribution of treatment on 
recovery
Geron, 
Ginsberg, & 
Solomon, 
2003
Professionally 
Lead
Group Adult N NA 21/21 NR 70 days; up 
to 10 
sessions
Perceived Social Support (PRQ); 
Perceived Stress (PSS)
Davis, 
Hoshiko, et 
al, 1992
Professionally 
Lead
Group Adult N NA 21/21 365–3650 52 days; up 
to 8 
sessions
Depression (CDI); Anxiety (HSC-
25); Knowledge of Death and 
Bereavement (KDBQ)
Stoddart, 
Burke, & 
Temple, 
2002
Professionally 
Lead
Group Adult N NA 20 90–1095 <1095 days; 
unlimited 
sessions
Grief (TRIG); Social Network 
(SNM, SNG)
Forte, 
Barrett, & 
Campbell, 
1996
Professionally 
Lead
Group Adult N NA 12/5 60–780 28 days; 8 
sessions
Emotional Distress (EPI); Family 
Adjustment (FACES-III); Social 
Adjustment (SAS-SR)
Heiney, 
Ruffin, & 
Goon-
Johnson, 
1995
Professionally 
Lead
Group Child Y Y-NE 17/17 >730 42 days; 6 
sessions
Self-Esteem (PH); Depression 
(CDI); Behavior (CBCL-TRF, 
CBCL-YSR)
Huss & 
Ritchie, 
1999
Professionally 
Lead
Group Child N NA 38/29 <900 300 days; 12 
sessions
Depression (BID); Attitude/ 
Conception of Death (ATCD)
Shilling, 
Koh, et al, 
1992
Professionally 
Lead
Group Child N NA 18/18 <730 52 days; 8 
sessions
Bereavement Survey (author 
created); Loss Resolution (LRS-
Modified); Distress and Somatic 
Complaints (ALAC)
Opie, 
Goodwin, 
Finke, et al, 
1992
Professionally 
Lead
Group Child N NA 6/6 240–1020 42 days; 6 
sessions
Psychological measures (Lewis 
Counselling Inventory, IPAT)
Quarmby, 
1993
Professionally 
Lead
Group Child N NA 4/4 <90 77 days; 11 
sessions
Self-Esteem (Piers-Harris Self-
Concept Scale); Descriptive (Risk 
Impact, Negative Chain Events, 
Opening Up Opportunities)
Zambelli & 
DeRosa, 
1992
Professionally 
Lead
Couple/ 
Marital
Adult Y Y-NE 57/31 NR Mean of 6 
sessions
Grief (TRIG); Irritability, 
Depression, Anger (IDA)
Lilford, 
Stratton, et 
al, 1994
Notes: * Families, not individuals. ** Study also included psychotherapy condition. Legend: Type, Type of Intervention; Format, Format of 
Intervention; Pop, Target Population; CG, Control Group; RA, Random Assignment; Num, Number of subjects; TSL, Time Since Loss; DT, 
Duration of Trial; NA, Not Applicable; NR, Not Reported; UC, Unclear; Y, Yes; N, No; Y-NE, Randomization mentioned, but allocation method 
not explicitly stated; RS, Randomization Subverted.
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Table 3: Psychotherapy Interventions
Type Format Pop CG RA Num TSL (days) DT Key Outcome Measures Article
Cognitive-
behavioral
Individual Senior Y N 58/NR 120–180 70 days; 4 
sessions
Mastery (Personal Mastery Scale); 
Well-being (MHI subscales, ABS 
Subscale, PERI self-esteem); 
Distress (PERI Demoralization 
Scales, MHI subscales)
Reich & 
Zautra, 
1989
Individual Senior N NA 4/4 540–730 98 days; 
14–18 
sessions
Distress (SUDS); Grief (ICG); 
Depression (BDI); Anxiety (BAI)
Harkness, 
Shear, et al, 
2002**
Individual Adult Y Y 30/25 >90 35 days; 10 
sessions
Avoidance/Intrusion (IES); Anxiety 
(SCL-90); Depression (SCL-90); 
Mood (POMS)
Lange, van 
de Ven, et 
al, 2001
Individual Adult Y Y-NE 26/14 180–7300 70 days; 6 
sessions
Depression (Wakefield, BDI); 
Physical Symptoms (Mawson et al, 
1981); Fear (FQ); Grief (TRIG); 
Avoidance (Bereavement 
Avoidance Tasks)
Sireling, 
Cohen, & 
Marks, 1988
Group Adult Y Y-NE 261/147 46–229 84 days; 8 
sessions
Mental Distress (BSI, GSI); PTS 
Symptoms (TES); Grief (GES); 
Physical Health (HHB); Marital 
Strain (DAS)
Murphy, 
Johnson, et 
al, 1998 
Murphy, 
1997
Group Adult Y Y-NE 110/80 ~730 28 days; 8 
sessions
Coping and Adaptation (TAT) Balk, Lampe, 
et al, 1998
Group Adult Y N 38/21 90–750 70 days; 10 
sessions
Treatment Expectancy 
(Expectancy Scale); Depression 
(BDI); Avoidance, Anxiety (Social 
Anxiety and Distress Scale); 
Enjoyability (Pleasant Events 
Scale); Life Satisfaction (Life 
Satisfaction Scale)
Walls & 
Meyers, 
1985
Group Adult N NA 8/8 >30 56 days; 8 
sessions
Avoidance/Intrusion (IES); 
Depression (BDI, SCL-90-R); 
Anxiety (SCL-90-R, STAI); Grief 
(GRI); Distress (PERI 
Demoralization)
Sikkema, 
Kalichman, 
et al, 
1995****
Group Child Y UC 19/18 <730 NR Behavior (BRIC-S, BRIC-H); 
Depression (DSRS); Grief (BP)
Hilliard, 
2001
Psycho-dynamic Individual Senior Y Y 228 ~60 <180 days; 
Unlimited 
sessions
Number of Office Visits, Types of 
Illnesses
Gerber, 
Wiener, 
Battin, et al, 
1975
Individual Senior Y Y-NE 33/30 90–1170 14 days; 4 
sessions
Mental Distress (BSI); Depression 
(GDS); Hopelessness (GHS); 
Avoidance/Intrusion (IES); Mood 
(PANAS)
Segal, 
Bogaards, et 
al, 1999
Individual Adult Y Y 66/56 <49 90 days; up 
to 9 
sessions
General Health(general health 
questionnaire)
Raphael, 
1977
Individual Adult Y N 72/63 60–462 12–20 
sessions
Avoidance/Intrusion (IES-A, IES-I); 
Depression (SCL-90); Anxiety 
(SCL-90); Total Pathology (SCL-
90); Stress-Intrusion (SRRS); 
Neurotic Symptoms (BPRS)
Horowitz, 
Weiss, et al, 
1984
Individual Adult N Y-NE 12/6 365–3650 196 days Depression (Wakefield); Grief 
(TRIG) Phobic Avoidance (FQ); 
Hostility/Anger/Guilt (HAG); 
Attitude to self and deceased 
(author-created scales); Avoidance 
(Bereavement Avoidance Tasks); 
Physical Symptoms (Maddison & 
Viola, 1968); Compulsive Behavior 
(Compulsive Activity Checklist); 
Social Adjustment (Watson & 
Marks, 1971)
Mawson, 
Marks, et al, 
1981BMC Palliative Care 2004, 3:3 http://www.biomedcentral.com/1472-684X/3/3
Page 9 of 14
(page number not for citation purposes)
bodily sensations or functions. Behavioral therapy was
used in only one study, which compared traumatic desen-
sitization to hypnotherapy and psychodynamic therapies
[69]. As described in the section on cognitive-behavioral
therapies above, all three therapies resulted in significant
improvements from pre- to post-treatment as compared
to controls, and no one therapy was found to be more
Individual Adult N NA 1/1 <180 112 days; 
10 sessions
Grief (Grief Scale); Coping (CRI) Orton, 1994
Group Senior Y Y 150/117 <365–7300 540 days; 6 
sessions
Depression (BDI); Socialization 
(RSAS)
Constantino
, 1988*****
Psycho-dynamic Group Adult Y Y-NE 56/53 120–330 8 sessions Depression, Anxiety, Somatization 
(Hopkins Symptom Checklist); 
Grief Intensity, Preoccupation, 
Guilt, Anger (Lieberman & Videka-
Sherman, 1986); Psychological 
Distress (Bradburn Affect Balance 
Scale); Locus of Control 
(Pearlman et al, 1981); Self-Esteem 
(Rosenberg scale, 1965); Social 
Adjustment (Pearlman et al, 1981, 
Lieberman & Videka-Sherman, 
1986)
Lieberman 
& Yalom, 
1992
Group Adult Y N 50/50 NR 90 days; 14 
sessions
Grief (TRIG) Sabatini, 
1988–89
Group Adult N Y 139/107 90–17155 84 days; 12 
sessions
Avoidance/Intrusion (IES); Grief 
(TRIG); Interpersonal Distress 
(IIP); Social Functioning (SAS-SR); 
Depression (BDI); Anxiety (STAI); 
Mental Distress (BSI, GSI); Self-
Esteem (SES); Physical Functioning 
(SF-36); Symptomatic Distress 
(SCL-90)
Piper, 
McCallum, 
et al, 2001*
Group Adult N Y-NE 61/55 120–1095 84 days; 12 
sessions
Avoidance/Intrusion (IES); Stress 
Symptoms (SRRS); Depression 
(BDI); Mental Distress (BPRS, 
SCL-90); Social Functioning (SAS-
SR); Overall Functioning (GAS)
Marmar, 
Horowitz, 
et al, 1988**
Group Child Y N 16/16 30–365 56 days Depression (CDI); Behavior (AP, 
AT); Grief (BP); Family alliance 
(TP); Grief, family relationship 
(TC)
Tonkins & 
Lambert, 
1996
Group Child N NA 45/37 30–3650 70 days Trauma (CPTSRI) Salloum, 
Avery, & 
McClain, 
2001
Psycho-analytic Group Adult N N 154/59 NR 84 days; 12 
sessions
Affect (author created); 
Psychodynamic Work (PWORS); 
Severity of objectives (author 
created)
McCallum, 
Piper, & 
Morin, 1993
Inter-personal Individual Senior Y Y-NE 80/66 216–279 112 days; 
up to 16 
sessions
Grief (TRIG) Reynolds, 
Miller, et al, 
1999***
Behavioral and 
Psycho-dynamic
Individual Adult Y N 83/83 <1825 15–20 
sessions
Anger (State Trait Anger 
Inventory); Anxiety (STAI); 
Avoidance/Intrusion (IES); 
Somatic/psychoneurotic 
symptoms (SCL-90); (Locus of 
Control Scale)
Kleber & 
Brom, 1987
Notes: * Study also included support/counselling condition. ** Treatment also included aspects of interpersonal psychotherapy. *** Study also 
included pharmacotherapy condition. **** Treatment also included aspects of social support. ***** Study also included social activities condition. 
Legend: Type, Type of Intervention; Format, Format of Intervention; Pop, Target Population; CG, Control Group; RA, Random Assignment; Num, 
Number of subjects; TSL, Time Since Loss; DT, Duration of Trial; NA, Not Applicable; NR, Not Reported; UC, Unclear; Y, Yes; N, No; Y-NE 
Randomization mentioned, but allocation method not explicitly stated.
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effective than the others in treating bereavement-related
symptoms.
Interpersonal therapy aims to improve communication
skills and increase self-esteem during a short time period
by focusing on a patient's behaviors and social interac-
tions with family and friends, directly teaching how better
to relate to others. Only one study used interpersonal
therapy as a bereavement care intervention, and this study
found no effect on grief as the only measured outcome
[6].
Systems-oriented interventions
Seven studies featured interventions that altered the man-
ner in which the healthcare system interacted with
patients, family, and friends prior to death, guided by an
underlying (yet not fully explicated) notion that interac-
tions experienced by loved ones prior to death can influ-
ence the subsequent bereavement process (Table 4) [73-
79]. Six of the seven interventions provided enhanced or
augmented care, in the form of palliative care, hospice
care, or care coordination. One intervention gave family
members the option of witnessing resuscitation efforts
[79]. Overall, the studies that reported systems-oriented
interventions produced mixed results of efficacy, with
only three of the seven studies showing any treatment
effect, mostly in long-term follow-up ranging from 60–
365 days post-death. In fact, no study found significant
treatment effects when measured during the intervention.
Ringdal and colleagues (2001) found no significant differ-
ences between those family members whose relative
received palliative care and those who received traditional
care [76]. This intervention, however, was not directed to
the bereaved relatives, but rather to their terminally ill rel-
atives. The bereaved relatives did show an overall signifi-
cant decline in TRIG grief scores over one year post-
bereavement for both palliative and traditional care
groups.
Robinson (1998) examined the psychological effect of
witnessing resuscitation efforts of patients in the emer-
gency room on bereaved relatives [79]. They found no
psychological differences between the control group who
did not witness the resuscitation attempt and the experi-
mental group who had the option of viewing the resusci-
tation effort. In fact, at the three- and nine-month follow
up, the experimental group exhibited median scores lower
(that is, better) than the controls on five of the eight meas-
ured scales. At nine months, the authors found the differ-
ence in TRIG2 scores approaching the 5% significance
level with a reported p = 0.08. These findings provide no
evidence to support the popular belief that relatives
should be excluded from the resuscitation room, and pro-
vide only weak evidence of possible psychological benefit
Table 4: Systems-Oriented Interventions
Intervention Pop CG RA Num Time of 
Evaluation
Key Outcome Measures Article
Care 
Coordination
Relative of 
cancer death
Y Y 94 365 days pre-death
56 days post-death
Anxiety (HADA, Leeds Depression and 
Anxiety Scale); Depression (HADD, Leeds 
Depression and Anxiety Scale); Social 
Support (Family Apgar Scale)
Addington, 
MacDonald, et 
al, 1992
Emergency 
Room
Relative of 
Emergency 
Room Death
Y N 100/66 180–365 days post-
death
Changes in satisfaction of care, information 
received (author-created questionnaire)
Adamowski, 
Dickinson, et al, 
1993
Hospice Care Relative of 
cancer death
Y Y-NE 96 42 days post-death
540 days post-death
Depression (CES-D); Anxiety (Rand Health 
Insurance Study); General Health (Rand 
Health Insurance Study); Social Functioning
Kane, Klein, et 
al, 1986
Palliative Care Relative of 
cancer death
Y Y 183 60–270 days pre-
death
390 days post-death
Grief (TRIG2) Ringdal, 
Jordhoy, et al, 
2001
Relative of 
cancer death
Y NR 119/49 0–60 days post-
death
Anxiety, Depression, Mental Exhaustion 
("observations and ratings")
Haggmark & 
Theorell, 1988
Relative of 
cancer death
Y N 49/37 365 days post-death Health, Anger, Mental State, Depression 
(Holland & Segroi's instrument)
Haggmark, 
Bachner, & 
Theorell, 1991
Witnessed 
Resuscitation
Relative of 
unsuccessful 
resuscitation
Y Y 18 30 days post-death 
90 days post-death
Grief (TRIG1, TRIG2); Avoidance/Intrusion 
(IESA, IESI); Depression (BDI, HADD); 
Anxiety (HADA, BAI)
Robinson, 
Makenzie-Ross, 
et al, 1998
Legend: Pop, Target Population; CG, Control Group; RA, Random Assignment; Num, Number of subjects; NR, Not Reported; Y, Yes; N, No; Y-NE 
Randomization mentioned, but allocation method not explicitly stated.BMC Palliative Care 2004, 3:3 http://www.biomedcentral.com/1472-684X/3/3
Page 11 of 14
(page number not for citation purposes)
of witnessed resuscitation; they do not, however, suggest
that having witnessed an unsuccessful resuscitation
attempt alleviates the grief reaction of the bereaved.
Discussion
When reviewed systematically, the current bereavement
intervention literature – notwithstanding the existence of
many intriguing reports – yields few reliable conclusions
to guide treatment. Good evidence supports the pharma-
cological treatment of depression occurring in the context
of bereavement. For all other forms of intervention, how-
ever, and for all attempts to diminish grief per se, no con-
sistent pattern of treatment benefit has been established
across well-designed experimental studies.
Why – despite prevalence of bereavement, the intense
dedication on the part of the bereavement research com-
munity, and the multitude of peer-reviewed published
bereavement studies – does the field of bereavement care
lack a formidable evidence base? In order to improve the
effectiveness and quality of bereavement care, this ques-
tion begs to be addressed. On the basis of our systematic
review of the literature, we postulate the following five
factors as hindering methodical scientific progress regard-
ing bereavement care interventions.
Excessive theoretical heterogeneity
As the history of science and medicine suggests, successful
scientific inquiry into a topic is typically a cumulative
process undertaken by a community of investigators
working within a shared scientific paradigm [80,81]. The
field of bereavement care intervention studies does not
appear to be organized in such a manner, but instead con-
sists of distinct groups of investigators working within dis-
parate theoretical frameworks: pharmacologic,
psychodynamic, psychoanalytic, behavioral, cognitive-
behavioral, interpersonal, and social supportive theories
each vie for attention. Indeed, although specification of
an underlying treatment-theory conceptual model may
improve causal inference [82], the bereavement care liter-
ature may be too invested in and reliant on theoretical jus-
tifications of treatments. Consequently, the compiled
published reports demonstrate a cumulative 'Tower of
Babel' phenomenon, with the different theory-dominated
perspectives failing to engage each other meaningfully:
the sum is no greater than the parts, and perhaps less.
Stultifying between-study variation
Treatments featured in published studies vary almost as
much as the authors who tested them. One can observe
substantial variation across studies regarding the type of
intervention generally or regarding the specific implemen-
tation of a specific type of intervention (such as different
doses of pharmaceuticals); regarding characteristics of
targeted patient populations; regarding outcome meas-
urements and study design methodology. Scrutinizing the
key outcome measures listed in the accompanying tables
illustrates this remarkable heterogeneity. Although these
differences have been due in part to diverse treatment-the-
ory paradigms, even studies conducted within the same
theoretical paradigm often differed markedly in terms of
what potential benefit was being tested, and how it was
being measured. Such substantial variation between stud-
ies stymies comparison or confirmation of treatment
effects.
Inadequate reporting of intervention procedures and 
implementation
Aside from the pharmacological studies, which reported
the dosing of the intervention medication, very few
reported studies describe the intervention procedures in
sufficient detail for readers to envision clearly what tasks
or activities intervention subjects were asked to perform.
This under-specification prevents sensible analysis, within
a class of treatments (such as cognitive-behavioral ther-
apy), of observed differences in treatment effects (since
the implementation of cognitive-behavioral therapy, for
instance, may have been quite different in seemingly sim-
ilar intervention studies).
Few published "replication" studies
Inadequate specification of intervention procedures, com-
bined with other factors at work within the community of
bereavement care investigators, may have resulted in the
dearth of published replication studies. This lack of repli-
cation prevents the accumulation of a body of evidence
that would confirm, refute, or refine prior estimates of
treatment effects.
Methodological study-design and data-analysis flaws
A final factor inhibiting research progress in the realm of
bereavement care interventions encompasses a number of
recurring methodological flaws that greatly limit infer-
ences regarding treatment effects. First and foremost is the
omission of control groups. Control groups are essential
for the valid evaluation of a bereavement intervention,
particularly because of the typically self-limited course of
grief: even absent any treatment, most bereaved people
show "diminished pathological symptoms and fewer
signs of disturbance within two years of the loss"[65]. Pur-
ported beneficial treatment effects observed in an inter-
vention group without a suitable control group therefore
may in fact be simply the natural grief remission process.
A second common study design feature is the non-ran-
dom assignment of study subjects into treatment and con-
trol groups, which again limits the strength of inference
regarding observed 'treatment' effects, as these differences
between treatment and control groups may be due to
selection or assignment bias. Third, many studies meas-
ured subject outcomes using untried assessment tools thatBMC Palliative Care 2004, 3:3 http://www.biomedcentral.com/1472-684X/3/3
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had been created on an ad hoc basis, and which may there-
fore have compromised measurement accuracy and infer-
ence validity. Lastly, studies that failed to demonstrate a
statistically-significant difference for the main outcome
measure often performed numerous post hoc subgroup
analyses, a practice that negates the rigor of statistical
hypothesis testing.
If these five factors are indeed hampering progress
towards improving bereavement care interventions and
quality of care for bereaved individuals, then concrete
actions could facilitate progress within the field of
bereavement care, specifically: 1) Convening a consensus-
building conference among key stakeholders and investi-
gators to define a specific research agenda that would
draw on a limited number of theoretical paradigms and
delineate key elements of treatment theory [82]; 2) Focus-
ing on interventions to improve key outcomes that are
valued by bereaved individuals; 3) Targeting well-defined
patient populations at well-defined phases of bereave-
ment; 4) Conducting high-quality randomized controlled
trial research designs, employing rigorous tests of hypoth-
eses defined prior to the conduct of the study, and eschew-
ing unplanned subgroup analyses; 5) Weighing the ethical
arguments for and against the use of randomized control
subjects in such research; 6) Increasing incentive to con-
duct and publish highly-comparable replication studies;
and 7) Enforcing the adoption of uniform standards
regarding clinical trial study reporting (such as outlined in
the CONSORT statement [83]) by journal editors and the
bereavement research community.
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